반응 #11684

ord-516d5b56df98453cafe3dd8cb1f58999

반응 방정식

C=CCN1C(=O)[C@@H](N)Cc2ccccc21.Cl
(S)-1-allyl-3-amino-3,4-dihydrocarbostyril hydrochloride
O=C(O)c1cc2cc(Cl)ccc2[nH]1
5-chloroindole-2-carboxylic acid
On1nnc2cccnc21
1-hydroxy-7-azabenzotriazole
CCN=C=NCCCN(C)C.Cl
1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride
CCN(C(C)C)C(C)C
Diisopropylethylamine
C=CCN1C(=O)[C@@H](NC(=O)c2cc3cc(Cl)ccc3[nH]2)Cc2ccccc21
title compound
수율 53.7%
C=CCN1C(=O)[C@@H](NC(=O)c2cc3cc(Cl)ccc3[nH]2)Cc2ccccc21
(S)-1-allyl-3-(5-chloroindole-2-carbonylamino)-3,4-dihydrocarbostyril
수율 53.7%

반응 조건

상세 조건
See reaction.notes.procedure_details.

후처리

  1. 1
    기타formed
  2. 2
    기타The solution was evaporated under vacuum
  3. 3
    기타the residue was directly purified by reverse phase preparative HPLC

실험 절차

(S)-1-allyl-3-amino-3,4-dihydrocarbostyril hydrochloride (7.6 mg) was added to a mixture of tetrahydrofuran (4 mL), 5-chloroindole-2-carboxylic acid (6.9 mg), 1-hydroxy-7-azabenzotriazole (5.5 mg), and 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride (7.7 mg) at room temperature. Diisopropylethylamine (12 mg) was added, and the resulting yellow suspension was stirred under argon for 16 h, during which a solution formed. The solution was evaporated under vacuum and the residue was directly purified by reverse phase preparative HPLC to provide the title compound (6.5 mg). HPLC/MS [M+H]+, 380; HPLC/MS [M+Na]+, 402.

출처

DOI: 10.6084/m9.figshare.5104873.v1특허: US07098235B2uspto-grants-2006_08